Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
IRWD Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
27.90%
Analyst Rating:
BUY
Analyst Forecast (1yr):
118.70%
IRWD Stock Analysis
IRWD
PE Ratio:
5.4
IRWD
PEG Ratio:
0.3
IRWD
Forward EPS Growth (12 month):
18.30%
IRWD
PS Ratio:
1.5
IRWD
PSG Ratio:
0.4
IRWD
Forward Revenue Growth (12 month):
4.10%
IRWD Articles
No data was found